Johnson & Johnson (JNJ) News

Express News | Johnson & Johnson Announces Ce Mark Approval for the New Ethicon™ 4000 Stapler

Breakings33minutes ago

Unusual Options Activity: EXPE, FLUT and Others Attract Market Bets, EXPE V/OI Ratio Reaches 70.2

EST Apr 21st Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options

Futu News01:30

Dow Drops 125 Points On Losses For Merck, Honeywell Stocks

MarketWatch00:56

Johnson & Johnson to Launch New AI Module for EP Mapping

MassDeviceApr 21 23:51

3 Dividend Aristocrats That Look Cheap and Just Hiked Payouts -- Barrons.com

Barron'sApr 21 22:15

Johnson & Johnson To Showcase Latest Advances Across Its Electrophysiology Portfolio At 2026 HRS Annual Meeting, Including New Evidence In PFA, And Cardiac Mapping & Imaging

BenzingaApr 21 19:51

CNBC financial expert: Avoid chasing overvalued AI stocks and shift to overlooked but fundamentally strong investment targets.

Gelonghui, April 21 | Jim Cramer, the well-known host of CNBC's financial program, warned that investors should avoid chasing popular stocks with 'parabolic rises,' as excessive buying often leads to losses. Instead, they should focus on overlooked stocks with solid fundamentals. Cramer pointed out that the recent surge in technology and semiconductor stocks driven by artificial intelligence themes has been too rapid, appearing 'overheated' to him. He frankly stated that past experiences show that when such rapidly rising stocks are bought, they often face pullback pressures. He specifically mentioned that AI concept stocks, including SanDisk, Intel, and AMD, have shown strong recent performance.

Gelonghui FinanceApr 21 10:16

BofA Says Corning Is Undervalued Heading Into Earnings — Here's Cramer's Take

CNBCApr 21 00:46

Semiconductors Look Dangerously Overheated After Massive Run: Analyst

BenzingaApr 21 00:40

We're Trimming a Stock Near Its 2026 Highs and Buying More of Our Newest Name

CNBCApr 20 20:56

Guggenheim Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $266

Futu NewsApr 20 19:31 · Ratings

Guggenheim Adjusts Price Target on Johnson & Johnson to $266 From $244, Maintains Buy Rating

MT NewswiresApr 20 19:25 · Ratings

Wall Street Analysts Are Bullish on Top Healthcare Picks

TipRanksApr 20 19:20 · Ratings

Earnings Scoreboard: 85% of S&P 500 Early Reporters Beat EPS Estimates as Y/Y Growth Hits 25 Firms

Seeking AlphaApr 18 21:30

Catalyst Watch: Tesla Talks AI5 Chips, Intel Reports, and the Warner Bros. Deal Goes to a Vote

Seeking AlphaApr 18 03:00

Unusual Options Activity: LYV, CP and Others Attract Market Bets, LYV V/OI Ratio Reaches 159.9

EST Apr 17th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.

Futu NewsApr 17 23:30

Dividend Roundup: Johnson & Johnson, Costco, Caterpillar, CVS Health, and More

Seeking AlphaApr 17 20:50

Barclays Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $255

Futu NewsApr 17 19:35 · Ratings

J.P. Morgan Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $260

Futu NewsApr 17 09:31 · Ratings

Marquis Who's Who Honors Mary Farinella for Leadership in Health Care Finance and Administration

PR NewswireApr 17 07:06